(Q37991383)

26 August 2017

Current and future pharmacological treatment strategies with regard to aortic disease in Marfan syndrome (English)

1 reference

26 August 2017

0 references

1 reference

1 reference

Romy Franken

2

0 references

Aeilko H Zwinderman

series ordinal

3

object named as

Aeilko H Zwinderman

1 reference

26 August 2017

Alexander W Hartog

1

1 reference

26 August 2017

Maarten Groenink

series ordinal

4

1 reference

26 August 2017

Barbara J M Mulder

series ordinal

5

1 reference

26 August 2017

language of work or name

English

0 references

publication date

7 March 2012

1 reference

Expert Opinion on Pharmacotherapy

26 August 2017

1 reference

26 August 2017

13

1 reference

26 August 2017

5

1 reference

26 August 2017

647-662

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

26 August 2017

1 reference

Clinical utility gene card for: Marfan syndrome type 1 and related phenotypes [FBN1]

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

The revised Ghent nosology for the Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Treatment of aortic disease in patients with Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Natural history of cardiovascular manifestations in Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Long-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Wolff-Parkinson-White syndrome in Marfan's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Intrinsic biventricular dysfunction in Marfan syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Left ventricular diastolic dysfunction in children and young adults with Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

The spectrum of cardiovascular disease in the Marfan syndrome: a clinico-morphologic study of 18 necropsy patients and comparison to 151 previously reported necropsy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Relation between age, arterial distensibility, and aortic dilatation in the Marfan syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Cardiovascular manifestations in men and women carrying a FBN1 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Aortic valve repair for aortic insufficiency in adults: a contemporary review and comparison with replacement techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Management of Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Cell signaling events: a view from the matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Angiotensin II receptors in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Angiotensin II induces vascular smooth muscle cell replication independent of blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Role of matrix metalloproteinases in abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

RGD-containing fibrillin-1 fragments upregulate matrix metalloproteinase expression in cell culture: a potential factor in the pathogenesis of the Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Imbalanced synthesis of cyclooxygenase-derived thromboxane A2 and prostacyclin compromises vasomotor function of the thoracic aorta in Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

β-Aminopropionitrile-induced dissecting aneurysms of turkeys: Treatment with propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

The effect of beta-blocker therapy on clinical outcome in patients with Marfan's syndrome: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Biophysical properties of the normal-sized aorta in patients with Marfan syndrome: evaluation with MR flow mapping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Aortic pressure-area relation in Marfan patients with and without beta blocking agents: a new non-invasive approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Beta-blocking therapy in patients with the Marfan syndrome and entire aortic replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Arterial hemodynamic indexes in Marfan's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Beta-blocker therapy does not alter the rate of aortic root dilation in pediatric patients with Marfan syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Aortic dissection in pregnancy: analysis of risk factors and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Obstetric complications in Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Maternal and fetal complications of pregnancy in the Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Maternal arrhythmias during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Pharmacologic treatment of hypertensive disorders during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Beyond the root: dilatation of the distal aorta in Marfan's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

The distal aorta in the Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Influence of arterial pulse and reflected waves on blood pressure and cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Antihypertensive therapy and wave reflections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Arterial hemodynamics in human hypertension. Effects of adrenergic blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Localized administration of doxycycline suppresses aortic dilatation in an experimental mouse model of abdominal aortic aneurysm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

In vivo optical molecular imaging of matrix metalloproteinase activity in abdominal aortic aneurysms correlates with treatment effects on growth rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Continuous periaortic infusion improves doxycycline efficacy in experimental aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Analysis of in situ and ex vivo vascular endothelial growth factor receptor expression during experimental aortic aneurysm progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Oxidative stress in the pathogenesis of thoracic aortic aneurysm: protective role of statin and angiotensin II type 1 receptor blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Association of statin prescription with small abdominal aortic aneurysm progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Angiotensin-converting enzyme inhibitors: a new mechanism of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Nitric oxide regulates local arterial distensibility in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Peripheral resistance vessel dysfunction in Marfan syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Medical therapy of thoracic aortic aneurysms: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Repair of aortic valve prolapse: experience with 44 patients*1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Mechanisms of Recurrent Aortic Regurgitation After Aortic Valve Repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Aortic dilatation in patients with bicuspid aortic valve

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Heterogeneous aortic response to acute β-adrenergic blockade in Marfan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2012.665446

10.1517/14656566.2012.665446

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference